• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Cross-species recognition of SARS-CoV-2 to bat ACE2

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2021 Jan 5;118(1):e2020216118.
doi: 10.1073/pnas.2020216118.
Cross-species recognition of SARS-CoV-2 to bat ACE2


Kefang Liu[SUP] 1 2 3 [/SUP], Shuguang Tan[SUP] 1 [/SUP], Sheng Niu[SUP] 1 4 [/SUP], Jia Wang[SUP] 5 [/SUP], Lili Wu[SUP] 1 2 6 [/SUP], Huan Sun[SUP] 1 [/SUP], Yanfang Zhang[SUP] 1 7 [/SUP], Xiaoqian Pan[SUP] 1 2 [/SUP], Xiao Qu[SUP] 1 [/SUP], Pei Du[SUP] 6 [/SUP], Yumin Meng[SUP] 1 [/SUP], Yunfei Jia[SUP] 1 4 [/SUP], Qian Chen[SUP] 1 8 [/SUP], Chuxia Deng[SUP] 3 [/SUP], Jinghua Yan[SUP] 6 9 [/SUP], Hong-Wei Wang[SUP] 5 [/SUP], Qihui Wang[SUP] 10 9 [/SUP], Jianxun Qi[SUP] 10 9 [/SUP], George Fu Gao[SUP] 10 9 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a major threat to global health. Although varied SARS-CoV-2-related coronaviruses have been isolated from bats and SARS-CoV-2 may infect bat, the structural basis for SARS-CoV-2 to utilize the human receptor counterpart bat angiotensin-converting enzyme 2 (bACE2) for virus infection remains less understood. Here, we report that the SARS-CoV-2 spike protein receptor binding domain (RBD) could bind to bACE2 from Rhinolophus macrotis (bACE2-Rm) with substantially lower affinity compared with that to the human ACE2 (hACE2), and its infectivity to host cells expressing bACE2-Rm was confirmed with pseudotyped SARS-CoV-2 virus and SARS-CoV-2 wild virus. The structure of the SARS-CoV-2 RBD with the bACE2-Rm complex was determined, revealing a binding mode similar to that of hACE2. The analysis of binding details between SARS-CoV-2 RBD and bACE2-Rm revealed that the interacting network involving Y41 and E42 of bACE2-Rm showed substantial differences with that to hACE2. Bats have extensive species diversity and the residues for RBD binding in bACE2 receptor varied substantially among different bat species. Notably, the Y41H mutant, which exists in many bats, attenuates the binding capacity of bACE2-Rm, indicating the central roles of Y41 in the interaction network. These findings would benefit our understanding of the potential infection of SARS-CoV-2 in varied species of bats.

Keywords: ACE2; COVID-19; RBD; Rhinolophus macrotis; SARS-CoV-2.
 
Back
Top Bottom